Feeling ’22: Mary Kay Inc. Announces Awards, Milestones, and Accomplishments From First Half of the Year
Garnering 30 awards—including ten employer awards—Mary Kay Inc. is recognized for its business excellence, social…
Garnering 30 awards—including ten employer awards—Mary Kay Inc. is recognized for its business excellence, social…
Demos of New ‘Sustainable Mining Solution’ Provided at Booth No. 56 on July 28 MIAMI…
PITTSBURGH–(BUSINESS WIRE)–The Federal Home Loan Bank of Pittsburgh (FHLBank) announced today unaudited financial results for…
Healthcare company selects Mayfield Graves Long-Term Recovery Group for second deployment of funding as part…
FREMONT, Calif. & CLEARWATER, Fla.–(BUSINESS WIRE)–TD SYNNEX announced today the launch of the most inclusive…
New sub-analysis on Trogarzo clinical trial patients demonstrates that long-term viral suppression is not influenced…
NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) — Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider…
Growing body of data supports Investigational New Drug (“IND”) application with the U.S. Food and…
JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy in adult…
SRT support ensures high-quality, secure streams directly from Media Composer for accelerated content review and…
Adds on-demand live support, easy setup for container image scanning and vulnerability reporting, a built-in…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
GRC will collaborate with Dell Technologies, Intel, and other data center and infrastructure experts to…
Announces Seed Funding of $4.2M to accelerate Kensu’s growth, open US Headquarters and continue to…
ECommerce platforms are fantastic for their adaptability and personalization. From a retail brand’s first forays…
Proceeds Will Be Used to Grow CURE’s Wellness and Beauty Brands and Its Remaining Proprietary…
•Independent peer-reviewed study confirms high potential for OligoPhoreTM delivery platform in RNA-based treatments for osteoarthritis…
Phase 2a trial initiation planned for the first half of 2023 subject to IND clearance…
MIAMI, July 28, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused…
CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…